SB INVESTMENT ADVISERS (UK) LTD
Follow13F filer, CIK 1731509, LONDON, United Kingdom
SB INVESTMENT ADVISERS (UK) LTD reported $12,614,836,435 across 10 holdings for the quarter ended 2025-06-30, in a 13F-HR/A filed 2025-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001493152-25-023523
- Period
- 2025-06-30
- Reported value
- $12.6B
- Holdings
- 10
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Part of the filer group SB INVESTMENT ADVISERS (UK) LTD
How groups are builtLargest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CPNGreduced | -40,000,000 | -$1.2B |
| YMMreduced | -3,841,674 | -$45.4M |
| ROIVreduced | -1,900,066 | -$21.4M |
| AURreduced | -2,597,722 | -$13.6M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2025
Share positions as resolved from 13F-HR/A 0001493152-25-023523, largest first. % of portfolio is the value over $12,614,836,435, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| CPNGCOUPANG INC | 309,542,259 | $9.27B | 73.52% | -40,000,000 | Timeline | ||
| GRABGRAB HOLDINGS LIMITED | 401,796,672 | $2.02B | 16.02% | 0 | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 59,952,652 | $676M | 5.36% | -1,900,066 | Timeline | ||
| COMPCOMPASS INC | 48,070,273 | $302M | 2.39% | 0 | Timeline | ||
| AURAURORA INNOVATION INC | 19,811,760 | $104M | 0.82% | -2,597,722 | Timeline | ||
| RLAYRELAY THERAPEUTICS INC | 27,904,963 | $96.6M | 0.77% | 0 | Timeline | ||
| VIRVIR BIOTECHNOLOGY INC | 16,684,041 | $84.1M | 0.67% | 0 | Timeline | ||
| YMMFULL TRUCK ALLIANCE CO LTD | 3,196,951 | $37.8M | 0.3% | -3,841,674 | Timeline | ||
| NRGVENERGY VAULT HOLDINGS INC | 18,535,631 | $13.3M | 0.11% | 0 | Timeline | ||
| DNAGINKGO BIOWORKS HOLDINGS INC | 610,729 | $6.87M | 0.05% | 0 | Timeline |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001641172-25-023674 | superseded | 2025-08-14 | acceptance time not in the bulk data set | ||
| 13F-HR/A 0001493152-25-023523 | base | restatement | 2025-11-14 | acceptance time not in the bulk data set |